Filters

Term Search
You can select from the dropdown list OR enter your own terms to refine the search.

Last Updated: 10/31/2025

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 56 publications

Myasthenia Gravis Treated with Zilucoplan Prior to Extended Transsternal Thymectomy for the Prevention of Myasthenic Crisis: A Case Report

Myasthenia Gravis Treated with Zilucoplan Prior to Extended Transsternal Thymectomy for the Prevention of Myasthenic Crisis: A Case Report

Journal: Brain and nerve = Shinkei kenkyu no shinpo
Published: August 18, 2025

Neuromuscular junction and the complement system.

Neuromuscular junction and the complement system.

Journal: International review of neurobiology
Published: July 17, 2025

Zilucoplan in myasthenic crisis refractory to conventional treatment: a report of two cases.

Zilucoplan in myasthenic crisis refractory to conventional treatment: a report of two cases.

Journal: Acta neurologica Belgica
Published: June 30, 2025

A comprehensive review of the treatment options in myasthenia gravis.

A comprehensive review of the treatment options in myasthenia gravis.

Journal: Disease-a-month : DM
Published: June 21, 2025

Zilucoplan for Successful Early Weaning From Mechanical Ventilation and Avoiding Tracheostomy in an 85-Year-Old Woman Experiencing Myasthenic Crisis: A Case Report.

Zilucoplan for Successful Early Weaning From Mechanical Ventilation and Avoiding Tracheostomy in an 85-Year-Old Woman Experiencing Myasthenic Crisis: A Case Report.

Journal: Cureus
Published: March 07, 2025

Zilucoplan as a fast-acting treatment for severe myasthenic exacerbation: A case series.

Zilucoplan as a fast-acting treatment for severe myasthenic exacerbation: A case series.

Journal: Revue neurologique
Published: March 06, 2025

Switching to subcutaneous zilucoplan from intravenous complement component 5 inhibitors in generalised myasthenia gravis: a phase IIIb, open-label study.

Switching to subcutaneous zilucoplan from intravenous complement component 5 inhibitors in generalised myasthenia gravis: a phase IIIb, open-label study.

Journal: Therapeutic advances in neurological disorders
Published: March 04, 2025

The Role of Complement in the Pathogenesis and Treatment of Myasthenia Gravis.

The Role of Complement in the Pathogenesis and Treatment of Myasthenia Gravis.

Journal: Cells
Published: March 01, 2025

Unmasking Anti-CASPR2 Syndrome in a Patient Treated for Myasthenia Gravis in the Era of New Treatments.

Unmasking Anti-CASPR2 Syndrome in a Patient Treated for Myasthenia Gravis in the Era of New Treatments.

Journal: European journal of neurology
Published: February 26, 2025

Efficacy and Safety of Zilucoplan in Amyotrophic Lateral Sclerosis: A Randomized Clinical Trial.

Efficacy and Safety of Zilucoplan in Amyotrophic Lateral Sclerosis: A Randomized Clinical Trial.

Journal: JAMA network open
Published: February 17, 2025

Changes in corticosteroid and non-steroidal immunosuppressive therapy with long-term zilucoplan treatment in generalized myasthenia gravis.

Changes in corticosteroid and non-steroidal immunosuppressive therapy with long-term zilucoplan treatment in generalized myasthenia gravis.

Journal: Journal of neurology
Published: February 14, 2025

Efficacy of zilucoplan in patients with generalised myasthenia gravis who have not previously received immunoglobulin or plasma exchange: A subgroup analysis from the Phase 3 RAISE study.

Efficacy of zilucoplan in patients with generalised myasthenia gravis who have not previously received immunoglobulin or plasma exchange: A subgroup analysis from the Phase 3 RAISE study.

Journal: Journal of the neurological sciences
Published: February 11, 2025
Showing 1-12 of 56

Last Updated: 10/31/2025